Prof. Erdem TÜZÜN


Aziz Sancar Institute of Experimental Medicine, Department of Neuroscience


Research Areas: Medicine, Health Sciences, Fundamental Medical Sciences, Internal Medicine Sciences, Neurology, Life Sciences, Neurobiology, Natural Sciences

Metrics

Publication

447

Citation (WoS)

5387

H-Index (WoS)

29

Citation (Scopus)

6532

H-Index (Scopus)

32

Project

77

Intellectual Property

3

Thesis Advisory

19

Open Access

22
UN Sustainable Development Goals

Education Information

2021 - 2022

2021 - 2022

Post Doctorate

University of Oxford, Neurology, England

2006 - 2007

2006 - 2007

Post Doctorate

University of Pennsylvania, Neurology, United States Of America

2001 - 2006

2001 - 2006

Post Doctorate

University of Texas at Austin, University Of Texas Medical Branch, Galveston, Tx, Abd, United States Of America

2000 - 2001

2000 - 2001

Post Doctorate

University of Oxford, Neurology, United Kingdom

1995 - 2000

1995 - 2000

Expertise In Medicine

Istanbul University, Istanbul Medical Faculty, Nöroloji, Turkey

1991 - 1995

1991 - 1995

Masters (Non-Thesis)

Istanbul University, Istanbul Medical Faculty, Turkey

1989 - 1991

1989 - 1991

Undergraduate

Istanbul University, Istanbul Medical Faculty, Turkey

Dissertations

2000

2000

Expertise In Medicine

Diabetes mellitus olgularında subklinik polinöropati araştırmasında F takeodispersiyonun yeri Sustainable Development

Istanbul University, Istanbul Medical Faculty, Nöroloji

Foreign Languages

C1 Advanced

C1 Advanced

English

Research Areas

Medicine

Health Sciences

Fundamental Medical Sciences

Internal Medicine Sciences

Neurology

Life Sciences

Neurobiology

Natural Sciences

Academic Titles / Tasks

2015 - Continues

2015 - Continues

Professor

Istanbul University, Aziz Sancar Institute of Experimental Medicine, Department of Neuroscience

2011 - 2015

2011 - 2015

Associate Professor

Istanbul University, Aziz Sancar Institute of Experimental Medicine, Department of Neuroscience

Managerial Experience

2021 - Continues

2021 - Continues

Neuro-oncology Board

EAN - European Academy of Neurology, Scientific Boards

2019 - 2022

2019 - 2022

Uluslararası İşbirliği Projeleri Araştırma Destek Grubu (UPAG)

The Scientific and Technological Research Council of Turkey

2012 - 2022

2012 - 2022

Head of Department

Istanbul University, Aziz Sancar Institute Of Experimental Medicine, Department of Neuroscience

Courses

Doctorate

Doctorate

Beynin Düzenleyici Sistemleri

Postgraduate

Postgraduate

Tümör İmmünolojisi

Postgraduate

Postgraduate

Sinir Sistemine Giriş

Doctorate

Doctorate

Sinirbilimde Hayvan Modelleri

Undergraduate

Undergraduate

Fizyolojiye Giriş

Expertise In Medicine

Expertise In Medicine

Seçmeli Nöroimmünoloji

Postgraduate

Postgraduate

Nöroimmünoloji

Doctorate

Doctorate

Laboratuar Rotasyonu

Doctorate

Doctorate

Kompleman sistemi

Advising Theses

2019

2019

Doctorate

Multiple skleroz patofizyolojisinde perisitlerin rolü

Tüzün E. (Advisor)

C.AYSEL(Student)

Published journal articles indexed by SCI, SSCI, and AHCI

2016

2016

Untitled

TÜZÜN E.

EPILEPSIES, vol.22, no.1, pp.5, 2016 (SCI-Expanded)

2000

2000

Out cold

Tuzun E.

NEW SCIENTIST, vol.168, no.2259, pp.56, 2000 (SCI-Expanded) identifier

Articles Published in Other Journals

Refereed Congress / Symposium Publications in Proceedings

2022

2022

Evaluation of SARS-CoV-2 Specific Antibody Responses in Asymptomatic and Symptomatic Cases.

Öktelik F. B., Yılmaz V., Gelmez M. Y., Akdeniz N., Köse M., Tüzün E., et al.

5th International Molecular Immunology and Immunogenetics Congress (MIMIC-V), İzmir, Turkey, 8 - 12 November 2022, pp.54 Sustainable Development

2022

2022

Silencing KCNS3 and FCRLB Genes in Experimental Model of MuSK Myasthenia Gravis: Two Novel Molecules in MG Pathogenesis

Koral G., Ulusoy C. A., Şahin H., Soylu S., Akbayır E., Tüzün E., et al.

5th International Molecular Immunology and Immunogenetics Congress (MIMIC V), İzmir, Turkey, 20 - 22 October 2022, pp.14

2022

2022

Evaluation of SARS-CoV-2 Specific Antibody Responses in Asymptomatic and Symptomatic Cases

Öktelik F. B., Yılmaz V., Gelmez M. Y., Akdeniz N., Köse M., Tüzün E., et al.

5th International Molecular Immunology and Immunogenetics Congress (MIMIC-V), İzmir, Turkey, 20 - 22 October 2022, pp.251

2022

2022

B cell gene expression profile in different demyelinating diseases

Karaaslan Z., Şanlı E., Yüceer H., Timirci Kahraman Ö., Gündüz T., Kürtüncü M., et al.

International Molecular Immunology & Immunogenetics Congress V (MIMIC V), İzmir, Turkey, 20 - 22 October 2022

2022

2022

Evaluation of SARS-CoV-2 Specific Antibody Responses in Asymptomatic and Symptomatic Cases.

Öktelik F. B., Yılmaz V., Gelmez M. Y., Akdeniz N., Köse M., Tüzün E., et al.

5th International Molecular Immunology & Immunogenetics Congress (MIMIC-V), İzmir, Turkey, 20 - 22 October 2022, pp.1 Sustainable Development

2022

2022

Serum 3-phenyllactic acid level is reduced in benign multiple sclerosis and is associated with effector B cell ratios

Tuzun E., Turkoglu R., Oezguen N., Yilmaz V., Akbayir E., Horvath T. D., et al.

38th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis, Amsterdam, Netherlands, 26 - 28 October 2022, vol.28, pp.778 identifier

2022

2022

Diagnostic and Theraputic Autoantibody Discovery Studies for Brain Tumors

Topçu O., Timirci Kahraman Ö., Sabancı P. A., Aras Y., Yetimler B., Mohr T., et al.

5th Annual Meeting New Diagnostic and Therapeautic Tools Against Multidrug Resistance Tumors, Coimbra, Portugal, 29 June - 01 July 2022, pp.50-51

2022

2022

NSC-87877, Inhibıtor Of Src Homology 2 Domain-Containing Phosphotyrosine Phosphatase 2, Ameliorates Experimental Autoimmune Myasthenia Gravis Induced By Musk Immunization

Yılmaz V., Koral G., Cao ., Liu W. W., Maxwell S., Webster R., et al.

14th MGFA International Conference On Myasthenia And Related Disorders, Florida, United States Of America, 10 - 12 May 2022, vol.65, pp.45

2021

2021

Immunothrombotic Markers in COVID-19 Pneumonia Concurrent Ischemic Stroke

Duran Bayar M., Şişman A. B., Çırak S., Erdağ E., Yılmaz V., Tüzün E., et al.

57. Ulusal Nöroloji Kongresi, Antalya, Turkey, 27 November - 01 December 2021 Sustainable Development

2021

2021

Şanlı E., Yılmaz V., Şirin Inan N. G., Koral G., Küçükali C. I., Bebek N., et al.

57. Ulusal Nöroloji Kongresi, Antalya, Turkey, 27 November - 01 December 2021

2021

2021

The role of SWAP-70 and FCRL2 in the pathophysiology of multiple sclerosis and their value as a biomarker.

Şanlı E., Şekerdağ-Yılmaz E., Erdağ Turgeon E., Akbayır E., Ulusoy C. A., Koral G., et al.

15th International Society of Neuroimmunology (ISNI) Congress, Antibes, France, 8 - 12 November 2021, pp.45

2021

2021

The role of SWAP-70 and FCRL2 in the pathophysiology of multiple sclerosis and their value as a biomarker

ŞANLI E., Şekerdağ Yılmaz E., ERDAĞ E., Akbayır E., ULUSOY C. A., Koral G., et al.

15th International Society of Neuroimmunology (ISNI) Congress, France (Virtual)., 8 - 12 November 2021

2021

2021

Can OSMS be differentiated from NMOSD and MS by peripheral blood immunophenotyping?

Şanlı E., Karaaslan Z., Yüceer H., Ulusoy C. A., Küçükali C. İ., Timirci Kahraman Ö., et al.

15th International Society of Neuroimmunology (ISNI) Congress, Nice, France, 8 - 12 November 2021

2019

2019

Cognitive assessment and cytokine profile of multiple sclerosis patients presenting with only optic neuritis and myelitis

TÜZÜN E., ARSOY E., AKBAYIR E., ŞEN M., MERCAN Ö., GENCER M., et al.

35th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) / 24th Annual Conference of Rehabilitation in MS, Stockholm, Sweden, 11 - 13 September 2019, vol.25, pp.849

2019

2019

Microarray Analysis Indicates Altered Expression Levels of B Cell Genes in Benign Multiple Sclerosis

TÜRKOĞLU R., AKBAYIR E., ŞEN M., YILMAZ V., KÜÇÜKALİ C. İ., TÜZÜN E.

71st Annual Meeting of the American-Academy-of-Neurology (AAN), Philadelphia, United States Of America, 4 - 10 May 2019, vol.92 Sustainable Development

2019

2019

DECREASED LEVELS OF Akt AND p-Akt1 IN PERIPHERAL CD4+CD25+CD127-/LOW REGULATOR T CELLS OF MULTIPLE SCLEROSIS PATIENTS

Öktelik F. B., YILMAZ V., Türkoğlu R., TÜZÜN E., DENİZ G., ÇINAR S.

International Molecular Immunology & Immunogenetics Congress IV ( MIMIC IV), Bursa, Turkey, 27 - 29 April 2019, vol.PA119, pp.118

2019

2019

The role of pericytes in MS pathophysiology.

Küçükali C. İ., Tüzün E., Ulusoy C. A., Özdemir Y.

VII. International Congress of Molecular Medicine, İstanbul, Turkey, 5 - 07 September 2019, pp.92-15

2019

2019

Effects of Fingolimod on Cytokine and Chemokine Levels in Patients with Multiple Sclerosis

Kurtuncu M., Yilmaz V., Akcay H. I., Turkoglu R., Altunrende B., Ulusoy C., et al.

71st Annual Meeting of the American-Academy-of-Neurology (AAN), Pennsylvania, United States Of America, 4 - 10 May 2019, vol.92 identifier